Skip to main content

Table 2 Tumour markers after the 3rd cycle of NAC and the interval surgery outcome (a) or first relapse (b)

From: Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer

(a)
  CC-0 (n = 16) CC-1+ (n = 14) p-value
CA125 ≤ 75 UI/ml 13 (81.3 %) 2 (12.3 %) 0.0007
HE4 ≤ 252 pmol/l 14 (87.5 %) 6 (42.8 %) 0.02
CA125 ≤ 75 UI/ml and HE4 ≤ 252 pmol/l 15 (93.7 %) 1 (7.1 %) 0.00001
(b)
  Relapse < 6 months (n = 12) Relape > 6 months (n = 18) p-value
CA125 ≤ 35 UI/ml 1 (8.3 %) 10 (55.5 %) 0.018
HE4 ≤ 115 pmol/l 1 (8.3 %) 13 (72.2 %) 0.0017
CA125 ≤ 35 UI/ml and HE4 ≤ 115 pmol/l 1 (8.3 %) 13 (72.2 %) 0.0017